Research from Dartmouth College demonstrates that certain bacteria can enhance their survival against medical treatments by forming dense clusters. The study, published in Current Biology, highlights a mechanism through which bacterial infections become increasingly difficult to treat, complicating existing therapeutic approaches.
The researchers focused on Escherichia coli, a common intestinal bacterium, and discovered that DNA molecules known as plasmids can manipulate host bacteria into developing tubular structures called conjugation pili. These appendages connect individual bacteria, creating clusters that can resist antibiotic treatment, even when the individual bacteria lack genetic resistance.
According to the study’s senior author, Carey Nadell, an associate professor of biological sciences, the findings reveal an alarming shift in how bacterial communities respond to treatment. “We’re not observing antibiotic resistance through genetic encoding, which is the typical pathway. Instead, plasmids enable bacterial cells to tolerate harm simply by altering their spatial arrangement,” Nadell stated.
The research indicates that a small number of plasmid carriers can infect nearly all bacterial cells within a biofilm in just three days. This rapid spread poses significant challenges for clinical treatments, particularly because biofilms, which are dense bacterial communities, often shelter cells that can evade antibiotic attacks. Nadell noted that current treatments typically target biofilms from the outside, leaving the inner cells protected and able to reproduce.
The study identified that bacterial clusters, formed through this plasmid-mediated process, are difficult to eliminate without extreme measures, such as high heat or bleach, which are not viable in clinical settings. “Treatments for infections are often ineffective against bacteria in a biofilm state,” Nadell explained.
In their experiments, the study’s first author, James Winans, found that while plasmids can enhance bacterial survival against antibiotics, they may also impair other vital functions, such as nutrient acquisition. The clustered bacteria become sluggish, which may limit their ability to disperse and find new resources. “If these dense clusters form within patients, that would pose a serious problem,” Winans remarked.
The findings also extend beyond E. coli. The researchers observed similar clustering effects with other bacterial species, including Salmonella enterica and Serratia fonticola. The team explored how interactions with additional microbes, such as the yeast Candida albicans and the pathogen Vibrio cholerae, influence plasmid transfer and cluster formation.
Looking ahead, the researchers plan to investigate how these bacterial communities enhance resistance to treatments. One hypothesis is that the dense clusters may impede the effectiveness of antibiotics, which often target actively growing cells. “Plasmids are prevalent in the natural environment, and it’s concerning to think they can collaborate with pathogenic bacteria against our clinical interventions,” Nadell stated.
The study underscores the need for new strategies to combat bacterial infections, particularly as the mechanisms of resistance become more sophisticated and intertwined with the behavior of bacterial communities. The insights gained from this research could pave the way for innovative approaches to treating stubborn infections, emphasizing the importance of understanding the dynamics of plasmid interactions in microbial populations.
